Diploma (LON:DPLM) Stock Crosses Above Two Hundred Day Moving Average – What’s Next?

Diploma PLC (LON:DPLM) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 4,573.70 ($61.96) and traded as high as GBX 5,470 ($74.10). Diploma shares last traded at GBX 5,470 ($74.10), with a volume of 174,166 shares changing hands.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the company. Berenberg Bank upped their price objective on Diploma from GBX 5,600 to GBX 5,750 and gave the company a “buy” rating in a research note on Friday, July 18th. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a GBX 4,440 price target on shares of Diploma in a research report on Wednesday, August 6th. Finally, Shore Capital reissued a “hold” rating and set a GBX 5,100 price objective on shares of Diploma in a report on Thursday, July 17th. Two equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of GBX 5,097.50.

Diploma Trading Up 1.0%

The company has a debt-to-equity ratio of 62.17, a quick ratio of 0.80 and a current ratio of 2.17. The stock has a market cap of £7.33 billion, a P/E ratio of 4,400.64, a P/E/G ratio of 2.82 and a beta of 0.75. The company has a 50-day simple moving average of GBX 5,186.93 and a 200-day simple moving average of GBX 4,573.70.

About Diploma

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.